Skip to main content
. 2020 Jul 31;7(9):1702–1707. doi: 10.1002/acn3.51065

Figure 2.

Figure 2

(A) Frequency of initial diagnosis before admission (n = 55/80) (PD, Parkinson’s disease; MSA, multiple system atrophy; FTD, frontotemporal dementia; MND, motor neuron disease; CBD, corticobasal degeneration; NPH, normal pressure hydrocephalus). (B) Frequency of PSP subgroups in our site according to movement disorder specialist opinion prior to new criteria (left column) versus new MDS‐PSP criteria (right column). (C) Frequency of PSP subgroups in our site according to movement disorder specialist opinion prior to new criteria (left column) versus new MDS‐PSP criteria (right column) when removing the group “PSP without subtype.” (D) Frequency of midbrain atrophy in MRI, either by neuroradiologist’s diagnosis (without specification how judged), by quantification of the MR parkinsonism index (MRPI) or by quantification of the midbrain to pons ratio.